Innospace's Historic Launch for South Korea's First Commercial Rocket Delayed by Weather
South Korean startup Innospace's first commercial rocket launch, Hanbit-Nano, has been delayed in Brazil due to bad weather. A successful launch would be a historic first for the country's private space sector.
South Korean space startup Innospace Co. confirmed on Monday that the launch of its Hanbit-Nano rocket, the nation's first-ever commercial orbital vehicle, has been pushed back due to unfavorable weather at its launch site in Brazil.
Rain Halts Countdown at Alcantara
The rocket was originally scheduled to lift off from the Alcantara Space Center at 3:45 p.m. local time, according to the company. However, with rain forecast for the afternoon, operators delayed the attempt until after 10 p.m. The company explained that once the rain stops, the rocket needs to be erected, a process that requires at least six hours of preparation before the final countdown can begin.
"It is difficult to forecast the exact time the rain will stop," Innospace said in a statement. "We will monitor weather conditions and announce the launch time later." This marks the third postponement since the original launch date of November 22.
High Stakes for a New Space Player
A successful mission would make Innospace the first private South Korean company to place a customer satellite into orbit, a significant milestone for the country's burgeoning space industry. The Hanbit-Nano is carrying a payload of five satellites intended for deployment into a 300-kilometer low orbit.
The two-stage vehicle is powered by a 25-ton thrust hybrid engine in its first stage, while the second stage employs a liquid methane and oxygen engine. Now, this advanced hardware is waiting on one of technology's oldest adversaries: the weather.
本コンテンツはAIが原文記事を基に要約・分析したものです。正確性に努めていますが、誤りがある可能性があります。原文の確認をお勧めします。
関連記事
韓国の宇宙スタートアップInnospaceが開発した同国初の商業軌道ロケット「Hanbit-Nano」の打ち上げが、ブラジルの発射場で悪天候のため延期されました。ミッションの重要性と技術仕様を解説します。
新型の円盤型衛星「DiskSat」が打ち上げ。20年にわたり標準だったCubeSatを超える存在となるか?宇宙産業の新たなパラダイムシフトを専門家が分析します。
米FDAが、ノボノルディスク社の人気肥満症治療薬「ウゴービ」の経口薬(ピル)を承認。注射と同等の効果を持ち、利便性が大幅に向上。2026年初頭に米国で発売予定。
米連邦通信委員会(FCC)が、国家安全保障上のリスクを理由に、外国製の新型ドローンの米国への輸入を原則禁止。DJIなど大手メーカーへの影響と、技術サプライチェーンの今後を分析します。